165 related articles for article (PubMed ID: 7578125)
21. Inhibition of human immunodeficiency virus type 1 integrase by 3'-azido-3'-deoxythymidylate.
Mazumder A; Cooney D; Agbaria R; Gupta M; Pommier Y
Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5771-5. PubMed ID: 8016063
[TBL] [Abstract][Full Text] [Related]
22. Intermolecular disintegration and intramolecular strand transfer activities of wild-type and mutant HIV-1 integrase.
Mazumder A; Engelman A; Craigie R; Fesen M; Pommier Y
Nucleic Acids Res; 1994 Mar; 22(6):1037-43. PubMed ID: 8152908
[TBL] [Abstract][Full Text] [Related]
23. Processing of deoxyuridine mismatches and abasic sites by human immunodeficiency virus type-1 integrase.
Mazumder A; Pommier Y
Nucleic Acids Res; 1995 Aug; 23(15):2865-71. PubMed ID: 7659508
[TBL] [Abstract][Full Text] [Related]
24. Mapping domains of retroviral integrase responsible for viral DNA specificity and target site selection by analysis of chimeras between human immunodeficiency virus type 1 and visna virus integrases.
Katzman M; Sudol M
J Virol; 1995 Sep; 69(9):5687-96. PubMed ID: 7637015
[TBL] [Abstract][Full Text] [Related]
25. Identification of a hexapeptide inhibitor of the human immunodeficiency virus integrase protein by using a combinatorial chemical library.
Puras Lutzke RA; Eppens NA; Weber PA; Houghten RA; Plasterk RH
Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11456-60. PubMed ID: 8524782
[TBL] [Abstract][Full Text] [Related]
26. Directed integration of viral DNA mediated by fusion proteins consisting of human immunodeficiency virus type 1 integrase and Escherichia coli LexA protein.
Goulaouic H; Chow SA
J Virol; 1996 Jan; 70(1):37-46. PubMed ID: 8523550
[TBL] [Abstract][Full Text] [Related]
27. Characterization of human immunodeficiency virus type 1 integrase expressed in Escherichia coli and analysis of variants with amino-terminal mutations.
Vincent KA; Ellison V; Chow SA; Brown PO
J Virol; 1993 Jan; 67(1):425-37. PubMed ID: 8416376
[TBL] [Abstract][Full Text] [Related]
28. A stable complex between integrase and viral DNA ends mediates human immunodeficiency virus integration in vitro.
Ellison V; Brown PO
Proc Natl Acad Sci U S A; 1994 Jul; 91(15):7316-20. PubMed ID: 8041787
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the minimal DNA-binding domain of the HIV integrase protein.
Lutzke RA; Vink C; Plasterk RH
Nucleic Acids Res; 1994 Oct; 22(20):4125-31. PubMed ID: 7937137
[TBL] [Abstract][Full Text] [Related]
30. Formation of a stable complex between the human immunodeficiency virus integrase protein and viral DNA.
Vink C; Lutzke RA; Plasterk RH
Nucleic Acids Res; 1994 Oct; 22(20):4103-10. PubMed ID: 7937134
[TBL] [Abstract][Full Text] [Related]
31. Dicaffeoylquinic acid inhibitors of human immunodeficiency virus integrase: inhibition of the core catalytic domain of human immunodeficiency virus integrase.
Robinson WE; Cordeiro M; Abdel-Malek S; Jia Q; Chow SA; Reinecke MG; Mitchell WM
Mol Pharmacol; 1996 Oct; 50(4):846-55. PubMed ID: 8863829
[TBL] [Abstract][Full Text] [Related]
32. Viral long terminal repeat substrate binding characteristics of the human immunodeficiency virus type 1 integrase.
Hazuda DJ; Wolfe AL; Hastings JC; Robbins HL; Graham PL; LaFemina RL; Emini EA
J Biol Chem; 1994 Feb; 269(6):3999-4004. PubMed ID: 8307956
[TBL] [Abstract][Full Text] [Related]
33. Human immunodeficiency virus type 1 integrase: effects of mutations on viral ability to integrate, direct viral gene expression from unintegrated viral DNA templates, and sustain viral propagation in primary cells.
Wiskerchen M; Muesing MA
J Virol; 1995 Jan; 69(1):376-86. PubMed ID: 7983732
[TBL] [Abstract][Full Text] [Related]
34. Rous sarcoma virus integrase protein: mapping functions for catalysis and substrate binding.
Bushman FD; Wang B
J Virol; 1994 Apr; 68(4):2215-23. PubMed ID: 8139006
[TBL] [Abstract][Full Text] [Related]
35. Cosalane analogues with enhanced potencies as inhibitors of HIV-1 protease and integrase.
Cushman M; Golebiewski WM; Pommier Y; Mazumder A; Reymen D; De Clercq E; Graham L; Rice WG
J Med Chem; 1995 Feb; 38(3):443-52. PubMed ID: 7853337
[TBL] [Abstract][Full Text] [Related]
36. Identification of discrete functional domains of HIV-1 integrase and their organization within an active multimeric complex.
Engelman A; Bushman FD; Craigie R
EMBO J; 1993 Aug; 12(8):3269-75. PubMed ID: 8344264
[TBL] [Abstract][Full Text] [Related]
37. Reversal of integration and DNA splicing mediated by integrase of human immunodeficiency virus.
Chow SA; Vincent KA; Ellison V; Brown PO
Science; 1992 Feb; 255(5045):723-6. PubMed ID: 1738845
[TBL] [Abstract][Full Text] [Related]
38. T30177, an oligonucleotide stabilized by an intramolecular guanosine octet, is a potent inhibitor of laboratory strains and clinical isolates of human immunodeficiency virus type 1.
Ojwang JO; Buckheit RW; Pommier Y; Mazumder A; De Vreese K; Esté JA; Reymen D; Pallansch LA; Lackman-Smith C; Wallace TL
Antimicrob Agents Chemother; 1995 Nov; 39(11):2426-35. PubMed ID: 8585721
[TBL] [Abstract][Full Text] [Related]
39. An essential interaction between distinct domains of HIV-1 integrase mediates assembly of the active multimer.
Ellison V; Gerton J; Vincent KA; Brown PO
J Biol Chem; 1995 Feb; 270(7):3320-6. PubMed ID: 7852418
[TBL] [Abstract][Full Text] [Related]
40. Site-directed mutagenesis of HIV-1 integrase demonstrates differential effects on integrase functions in vitro.
Leavitt AD; Shiue L; Varmus HE
J Biol Chem; 1993 Jan; 268(3):2113-9. PubMed ID: 8420982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
